美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Invesco Dorsey Wright Healthcare Momentum ETF

60.98

-0.6309-1.02%

成交量：3.43萬

成交額：208.34萬

市值：2.85億

市盈率：19.95

高：61.59

開：61.59

低：60.44

收：61.61

52周最高：64.10

52周最低：39.36

股本：467.00萬

流通股本：467.00萬

量比：2.66

換手率：0.73%

股息：1.53

股息率：2.51%

每股收益(TTM):3.06

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

美國FDA批准胰腺癌突破性藥物獨立藥企Revolution Medicines迎里程碑

环球市场播报

石藥集團在石家莊成立健康創新科技公司

Priovant宣佈FDA批准Lisraya™（Brepocitinib）用於成人皮肌炎治療；現已在美國上市

美國FDA批准了Roivant-Priovant公司的一款皮膚病藥物

Street View：Revolution的胰腺癌藥物獲批，開啓「變革性」時代

錦波生物中報遇冷：重組膠原蛋白龍頭高增長敍事遇考驗

傑富瑞：將Revolution Medicines目標價從242美元上調至270美元。

Brightspring Health Services Inc(BTSG)股票8月26日收盤上漲7.20%：背後推手曝光

TradingKey中文

Revolution Medicines旗下Rasonque美國正式上市，30天療程批發採購價39,800美元——電話會議披露

美國FDA批准Revolution Medicines旗下Rasonque™（Daraxonrasib）上市，開創轉移性胰腺癌廣譜Ras靶向治療先河

BUZZ——美國股市動態-Revolution Medicines、Abercrombie & Fitch、Williams-Sonoma

Revolution Medicines的胰腺癌藥物 Daraxonrasib已獲得美國監管機構的批准，這是首款針對胰腺

《JAMA皮膚病學》發布Brepocitinib治療皮肌炎3期VALOR試驗皮膚特異性結果

美國食品藥品監督管理局（FDA）批准了Revolution Medicines公司的一款胰腺癌藥物

江蘇：推動相關縣聚焦創新藥和高端醫療器械等產業，建立「N個1」培育機制，因地制宜發展特色優勢產業

江蘇：加快培育一批研發創新能力強、國際化水平高的世界一流製藥集團與醫療器械領軍企業

採納股份：全資子公司取得一次性使用人體動脈血樣採集器醫療器械註冊證

三力製藥在陝西成立藥品銷售新公司

康拓醫療：控股子公司取得第三類醫療器械註冊證

步長製藥等成立新公司註冊資本5000萬元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/PTH/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":60.98,"timestamp":1789490111281,"preClose":61.6109,"halted":0,"volume":34322,"delay":0,"changeRate":-0.010240071156240276,"floatShares":4670000,"shares":4670000,"eps":3.057033,"marketStatus":"交易中","change":-0.6309,"latestTime":"09-15 12:41:10 EDT","open":61.585,"high":61.585,"low":60.44,"amount":2083446.30668,"amplitude":0.018584,"askPrice":61.01,"askSize":375,"bidPrice":60.91,"bidSize":100,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":61.6109,"sharesOutstanding":2480000,"nav":60.75567,"aum":283728978.9,"dividendRate":0.025057,"bidAskSpread":0.001903,"postHourTrading":{"tag":"盘后","latestPrice":61.66,"preClose":61.6109,"latestTime":"19:30 EDT","volume":13,"amount":800.5754,"timestamp":1789428602402,"change":0.0491,"changeRate":0.000797,"amplitude":0},"volumeRatio":2.664802,"impliedVol":0.1533,"impliedVolPercentile":0.745},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4670000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.664802,"shares":4670000,"dividePrice":1.528,"high":61.585,"amplitude":0.018584,"preClose":61.6109,"low":60.44,"week52Low":39.36,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":60.98,"committee":-0.578947,"eps":3.057033,"divideRate":0.025057,"volume":34322,"delay":0,"ttmEps":3.057033,"open":61.585,"prevYearClose":49.701,"prevWeekClose":60.7692,"prevMonthClose":60.7941,"prevQuarterClose":59.76,"fiveDayClose":61.7173,"twentyDayClose":60.8616,"sixtyDayClose":52.9818},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662061828","title":"美國FDA批准胰腺癌突破性藥物 獨立藥企Revolution Medicines迎里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=2662061828","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662061828?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 18:15","pubTimestamp":1787912149,"startTime":"0","endTime":"0","summary":"Revolution Medicines历时近十年持续攻关，在500人规模临床试验中获得积极数据，最终获得监管批准。为完成交易，戈德史密斯与Warp Drive最大股东赛诺菲协商，将后者持有的Warp Drive多数股权置换为Revolution Medicines的部分股权，最终达成协议。在正式获批前，美国食品药品管理局已通过同情用药项目允许Revolution Medicines提前约四个月向患者分发药物，截至获批时已有超过2000名患者纳入该项目。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-28/doc-inipwhrt5845666.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["LABU","BBH","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","PTH","BK4588","IE00B4R5TH58.HKD","BK4585","LU0109394709.USD","IDNA","IE0009354923.USD","LU0320765992.SGD","IE00BJT1NW94.SGD","IE0002141913.USD","CANC","IE0009355771.USD","IE00BJJMRZ35.SGD","RVMD","LU0889565916.HKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662059157","title":"石藥集團在石家莊成立健康創新科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2662059157","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662059157?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 13:58","pubTimestamp":1787896694,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IEIH","HART","PTH","LGHT","RSPH","MEDX","AGNG","GDOC","MDEV","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141500682","title":"Priovant宣佈FDA批准Lisraya™（Brepocitinib）用於成人皮肌炎治療；現已在美國上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1141500682","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141500682?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 03:29","pubTimestamp":1787858949,"startTime":"0","endTime":"0","summary":"Priovant今日宣布，美国食品药品监督管理局（FDA）已正式批准Lisraya™（Brepocitinib）用于治疗成人皮肌炎患者。这一里程碑式的决定意味着该药物现已即刻在美国市场供应。\n皮肌炎是一种罕见的自身免疫性疾病，以肌肉无力和特征性皮疹为主要表现，长期以来困扰着众多患者。此次获批为这一患者群体带来了全新的治疗选择。\nLisraya™作为一种创新疗法，其获批上市标志着皮肌炎治疗领域取得了重大突破。该药物目前已可及，符合条件的患者将能够立即获得这一新的治疗方案的处方。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV","PTH","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662308069","title":"美國FDA批准了Roivant-Priovant公司的一款皮膚病藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2662308069","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662308069?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 03:26","pubTimestamp":1787858803,"startTime":"0","endTime":"0","summary":"美国FDA批准了Roivant-Priovant公司的一款皮肤病药物路透8月27日-美国食品和药物管理局周四表示，已批准Roivant公司（ROIV.O）及其合作伙伴Priovant Therapeutics公司研发的一种用于治疗皮肌炎的药物，这使其成为首款用于治疗该皮肤病的口服药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4T44O1TT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","BK4007","ROIV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662704894","title":"Street View：Revolution的胰腺癌藥物獲批，開啓「變革性」時代","url":"https://stock-news.laohu8.com/highlight/detail?id=2662704894","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662704894?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 19:36","pubTimestamp":1787830591,"startTime":"0","endTime":"0","summary":"BUZZ-Street View：Revolution的胰腺癌药物获批，开启“变革性”时代8月27日-** Revolution Medicines旗下RVMD.O公司研发的、具有突破性的  胰腺癌药物Rasonque于周三获得美国FDA批准** RVMD股价盘前上涨3%，报222美元；该股平均评级为“买入”，目标价中位数为240美元——路孚特数据** 监管部门批准后，至少有7位分析师上调了目标价化疗后时代来临？","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4T44O15A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","BK4139","IE00BJJMRZ35.SGD","CANC","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE0002141913.USD","IE0009355771.USD","IDNA","IE00BJT1NW94.SGD","PTH","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD","IE00BFTCPJ56.SGD","IE0009354923.USD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662677438","title":"錦波生物中報遇冷：重組膠原蛋白龍頭高增長敍事遇考驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2662677438","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662677438?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 16:36","pubTimestamp":1787819760,"startTime":"0","endTime":"0","summary":"近日，重组胶原蛋白头部企业锦波生物发布2026年半年报。02高毛利光环之下，行业周期与研发投入暗藏长期风险锦波生物依旧拥有行业内较高毛利率，但是高毛利已经难以维持高增长，赛道内卷正在逐步侵蚀原有优势。同行对比来看，巨子生物占据营收龙头位置，创尔生物处于规模爬坡阶段，行业竞争进一步加剧，锦波生物高毛利优势正被增长乏力抵消。对于锦波生物而言，护肤品业务的增长，暂时无法弥补医疗器械主业的下滑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-08-27/doc-iniptxkt9108819.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","BK1574","HART","BK1100","PTH","MDEV","IEIH","LGHT","GDOC","RSPH","AGNG","LNGR","09996","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662722025","title":"傑富瑞：將Revolution Medicines目標價從242美元上調至270美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662722025","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662722025?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 11:50","pubTimestamp":1787802605,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CANC","IDNA","PTH","IE00B4R5TH58.HKD","UDN","UUP","BBH","IE0009355771.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE0009354923.USD","IE00BJT1NW94.SGD","LU0320765992.SGD","IE00B2B36J28.USD","LU0109394709.USD","IE0002141913.USD","RVMD","IE00BFTCPJ56.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662195744","title":"Brightspring Health Services Inc(BTSG)股票8月26日收盤上漲7.20%：背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2662195744","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662195744?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 04:16","pubTimestamp":1787775368,"startTime":"0","endTime":"0","summary":"• BrightSpring公布了强劲的第二季度营收，并上调了全年业绩指引。\n• 华尔街分析师维持“买入”评级，平均目标价为78.97美元。\n• 全年营收达129.1亿美元，净利润为1.9067亿美元。","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262133913-market-movers-btsg-20260826","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","LU2089984988.USD","PSCH","PTH","LU2468319806.SGD","BTSG","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164882019","title":"Revolution Medicines旗下Rasonque美國正式上市，30天療程批發採購價39,800美元——電話會議披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1164882019","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164882019?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 01:57","pubTimestamp":1787767031,"startTime":"0","endTime":"0","summary":"Revolution Medicines公司日前宣布，其研发的Rasonque药物现已在美国市场正式商业化供应。这款产品的批发采购成本定为39,800美元，对应30天的用药剂量。值得注意的是，此次上市定价反映了Rasonque在精准肿瘤治疗领域的差异化价值主张。从商业角度看，这一价格策略也释放出Revolution Medicines对其产品竞争力的强烈信心。分析人士指出，随着Rasonque正式进入流通渠道，相关供应链与市场准入工作已全面启动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","BK4139","IDNA","IE00B4R5TH58.HKD","IE0009354923.USD","LU0889565916.HKD","RVMD","IE0002141913.USD","IE00BJT1NW94.SGD","BBH","PTH","IE00BFTCPJ56.SGD","CANC","IE00B2B36J28.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156385670","title":"美國FDA批准Revolution Medicines旗下Rasonque™（Daraxonrasib）上市，開創轉移性胰腺癌廣譜Ras靶向治療先河","url":"https://stock-news.laohu8.com/highlight/detail?id=1156385670","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156385670?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 01:00","pubTimestamp":1787763644,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局正式批准了Revolution Medicines研发的Rasonque——这标志着全球首款针对转移性胰腺癌的广谱Ras靶向药物成功问世。此举不仅为晚期胰腺癌患者带来了全新的治疗选项，更在肿瘤精准医疗领域树立起一座重要的里程碑。此次获批，无疑将深刻影响胰腺癌治疗的现有格局。对于广大深受胰腺癌困扰的患者群体而言，Rasonque的上市，无疑为他们与病魔的抗争增添了一件有力武器。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4139","IE00BJJMRZ35.SGD","IE0002141913.USD","CANC","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0109394709.USD","LU0320765992.SGD","IE0009355771.USD","IDNA","IE0009354923.USD","IE00BFTCPJ56.SGD","RVMD","BBH","PTH","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662436927","title":"BUZZ——美國股市動態-Revolution Medicines、Abercrombie & Fitch、Williams-Sonoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2662436927","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662436927?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 23:45","pubTimestamp":1787759102,"startTime":"0","endTime":"0","summary":".N美国东部时间11:30，道琼斯工业平均指数.DJI下跌0.25%，报53,444.86点。标普500指数.SPX下跌0.02%，报7,675.90点；纳斯达克综合指数.IXIC下跌0.20%，报26,098.72点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL4S44N1B5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","IE00B4R5TH58.HKD","BK4585","IE0002141913.USD","RVMD","BK4139","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0109394709.USD","PTH","BK4178","LU0942090050.USD","LU0320765992.SGD","LU0889565916.HKD","IE0009354923.USD","LU0170899867.USD","IE00B2B36J28.USD","BBH","IE00BFTCPJ56.SGD","WSM","BK4588","ANF","IDNA","LU0868494708.USD","CANC","BK4094","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662482997","title":"Revolution Medicines的胰腺癌藥物 Daraxonrasib已獲得美國監管機構的批准，這是首款針對胰腺","url":"https://stock-news.laohu8.com/highlight/detail?id=2662482997","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662482997?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 23:14","pubTimestamp":1787757271,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B2B36J28.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU0320765992.SGD","BBH","RVMD","PTH","IDNA","IE0009355771.USD","CANC","IE00BJT1NW94.SGD","BK4139","IE0002141913.USD","IE0009354923.USD","IE00B4R5TH58.HKD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169456208","title":"《JAMA皮膚病學》發布Brepocitinib治療皮肌炎3期VALOR試驗皮膚特異性結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1169456208","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169456208?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 23:12","pubTimestamp":1787757130,"startTime":"0","endTime":"0","summary":"《JAMA皮肤病学》杂志正式刊发了Brepocitinib在皮肌炎治疗中的3期VALOR试验皮肤特异性结局数据。这项研究聚焦于皮肤相关症状的改善情况，为这一罕见自身免疫性疾病的治疗提供了新的临床证据。该试验结果此前已引起业界广泛关注，如今皮肤特异性数据的公布，进一步丰富了人们对Brepocitinib疗效维度的理解。皮肌炎以皮肤和肌肉炎症为特征，皮肤表现往往对患者生活质量造成显著影响，因此这一数据的发布具有重要临床意义。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PTH","BK4139","ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662271008","title":"美國食品藥品監督管理局（FDA）批准了Revolution Medicines公司的一款胰腺癌藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2662271008","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662271008?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 22:44","pubTimestamp":1787755452,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）批准了Revolution Medicines公司的一款胰腺癌药物路透8月26日-美国食品药品监督管理局周三表示，已批准Revolution Medicines公司用于治疗转移性胰腺癌的靶向药物RVMD.O。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL4T44N176:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU0320765992.SGD","IE00BJJMRZ35.SGD","LU0889565916.HKD","PTH","CANC","IE00B4R5TH58.HKD","IE0009354923.USD","IE0002141913.USD","IE00BJT1NW94.SGD","LU0109394709.USD","RVMD","BK4139","IE0009355771.USD","IE00BFTCPJ56.SGD","IDNA","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662471794","title":"江蘇：推動相關縣聚焦創新藥和高端醫療器械等產業，建立「N個1」培育機制，因地制宜發展特色優勢產業","url":"https://stock-news.laohu8.com/highlight/detail?id=2662471794","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662471794?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 17:43","pubTimestamp":1787737421,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","IEIH","RSPH","IBBQ","MDEV","AGNG","HART","GDOC","LGHT","PTH","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662779444","title":"江蘇：加快培育一批研發創新能力強、國際化水平高的世界一流製藥集團與醫療器械領軍企業","url":"https://stock-news.laohu8.com/highlight/detail?id=2662779444","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662779444?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 17:43","pubTimestamp":1787737395,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IEIH","GDOC","AGNG","PTH","MDEV","RSPH","LNGR","HART","MEDX","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662795505","title":"採納股份：全資子公司取得一次性使用人體動脈血樣採集器醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2662795505","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662795505?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 15:59","pubTimestamp":1787731173,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LNGR","HART","IEIH","LGHT","MDEV","AGNG","PTH","GDOC","MEDX","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662276595","title":"三力製藥在陝西成立藥品銷售新公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2662276595","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662276595?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 08:53","pubTimestamp":1787705590,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG","RSPH","MDEV","LGHT","MEDX","GDOC","IEIH","LNGR","HART","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662808847","title":"康拓醫療：控股子公司取得第三類醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2662808847","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662808847?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 17:13","pubTimestamp":1787649205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PTH","IEIH","MDEV","RSPH","LNGR","LGHT","HART","MEDX","AGNG","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662788168","title":"步長製藥等成立新公司 註冊資本5000萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662788168","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662788168?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 11:09","pubTimestamp":1787627361,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDEV","LNGR","HART","IEIH","PTH","RSPH","LGHT","MEDX","AGNG","GDOC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}